Lupus Erythematosus

GPTKB entity

Statements (47)
Predicate Object
gptkbp:instanceOf autoimmune disease
gptkbp:affects gptkb:skin
brain
heart
lungs
kidneys
joints
gptkbp:causedBy immune system attacking healthy tissue
gptkbp:complication gptkb:anemia
heart disease
stroke
kidney failure
infection
lung inflammation
gptkbp:diagnosedBy blood test
clinical evaluation
urine test
gptkbp:firstDescribed 19th century
https://www.w3.org/2000/01/rdf-schema#label Lupus Erythematosus
gptkbp:ICD-10_code gptkb:M32
gptkbp:MeSH_ID D008180
gptkbp:prevalence more common in women
onset usually between ages 15 and 45
gptkbp:riskFactor African descent
genetic predisposition
Asian descent
female sex
environmental triggers
Hispanic descent
gptkbp:subspecies gptkb:Discoid_Lupus_Erythematosus
gptkb:Drug-induced_Lupus_Erythematosus
gptkb:Neonatal_Lupus_Erythematosus
gptkb:Subacute_Cutaneous_Lupus_Erythematosus
gptkb:Systemic_Lupus_Erythematosus
gptkbp:symptom fever
fatigue
joint pain
hair loss
photosensitivity
skin rash
mouth ulcers
gptkbp:treatment gptkb:NSAIDs
antimalarial drugs
corticosteroids
immunosuppressants
gptkbp:bfsParent gptkb:LE
gptkbp:bfsLayer 6